PI-RADS guidelines use quantitative mono-exponential apparent diffusion coefficient (ADC) for risk stratification of small potentially aggressive prostate cancer (PCa). Inherently, multi-exponential diffusion in complex tumor microenvironment, limits accuracy of ADC-based thresholds and clinical utility of DWI acquisition protocols. Biomimetic phantoms that provide ground-truth diffusion parameters help establish accuracy of advanced multi-b DWI protocols and parametric diffusion models in prostate tumors. This work demonstrates development of stable phantoms based on lipid nanoparticles that provide diffusion parameter ranges typical of PCa.
This abstract and the presentation materials are available to members only; a login is required.